PCVX

Vaxcyte (PCVX)

Vaxcyte Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:PCVX

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/11	05:19	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PCVX	Vaxcyte Inc
2024/06/11	05:13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/06/11	05:12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/06/11	05:11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/06/11	05:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/06/06	05:58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/06/06	05:57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/06/04	05:02	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/06/04	05:00	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/05/25	06:05	Edgar (US Regulatory)	Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers	NASDAQ:PCVX	Vaxcyte Inc
2024/05/09	05:10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PCVX	Vaxcyte Inc
2024/05/09	05:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PCVX	Vaxcyte Inc
2024/05/09	05:05	GlobeNewswire Inc.	Vaxcyte Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:PCVX	Vaxcyte Inc
2024/04/03	05:05	GlobeNewswire Inc.	Vaxcyte to Present at the 23rd Annual Needham Virtual Healthcare Conference	NASDAQ:PCVX	Vaxcyte Inc
2024/03/05	11:23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/03/05	11:22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/03/05	11:21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/03/04	22:30	GlobeNewswire Inc.	Vaxcyte Completes Enrollment of Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease (IPD) in Infants	NASDAQ:PCVX	Vaxcyte Inc
2024/03/02	06:02	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/03/02	06:00	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/02/28	06:58	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:PCVX	Vaxcyte Inc
2024/02/28	06:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PCVX	Vaxcyte Inc
2024/02/28	06:01	GlobeNewswire Inc.	Vaxcyte Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	NASDAQ:PCVX	Vaxcyte Inc
2024/02/21	06:22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/02/16	06:05	GlobeNewswire Inc.	Vaxcyte to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024	NASDAQ:PCVX	Vaxcyte Inc
2024/02/06	07:39	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/02/06	07:37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/02/03	08:39	GlobeNewswire Inc.	Vaxcyte Announces Closing of $862.5 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares	NASDAQ:PCVX	Vaxcyte Inc
2024/02/02	06:07	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PCVX	Vaxcyte Inc
2024/02/02	06:06	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PCVX	Vaxcyte Inc